文献速递认知障碍与痴呆癫痫

正常认知与轻度认知障碍人群中癫痫发作控制与认知的关联

Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment.
PubMed 文献 · Neurology · 2024-08-22

基于美国39个阿尔茨海默病中心2005年9月至2021年12月的纵向多中心队列数据,纳入正常认知和轻度认知障碍(MCI)参与者。活动性癫痫发作与正常认知者认知损害风险升高(aHR 2.13)及MCI者痴呆风险升高(aHR 1.58)相关,而远程发作未见此风险。

要点

  • 活动性癫痫发作与正常认知者认知损害风险升高相关(aHR 2.13,95%CI 1.60-2.84)。
  • 活动性癫痫发作与MCI者痴呆风险升高相关(aHR 1.58,95%CI 1.24-2.01)。
  • 远程发作未观察到与认知下降的风险关联。

核心结论

  • 活动性癫痫发作而非远程发作与正常认知者和MCI者更早的认知下降相关,且独立于其他痴呆风险因素。
  • 作者认为早期识别和管理癫痫发作可能为减轻老龄化癫痫人群的认知下降提供途径。

研究设计与样本

  • 纵向多中心队列研究,基于美国国家阿尔茨海默病协调中心数据,参与者来自美国39个阿尔茨海默病中心,招募时间为2005年9月至2021年12月。
  • 纳入所有正常认知和MCI且至少2次访视的参与者;正常认知组13726人(9002名女性[66%],中位年龄71岁),MCI组11372人(5605名女性[49%],中位年龄73岁)。
  • 主要结局为认知下降,使用临床痴呆评定量表(CDR)判定:正常至损害(CDR≥0.5)和MCI至痴呆(CDR≥1)。
  • 比较活动性癫痫发作(过去12个月内)、远程发作(既往发作但过去12个月内无发作)和无发作(对照)对认知的影响,并分析入组时慢性发作和新发发作亚组。
  • 采用Cox回归模型评估全因MCI和/或痴呆风险,所有模型均校正年龄、性别、教育、种族、高血压和糖尿病。

主要发现

  • 正常认知组中,118人有活动性发作,226人有远程发作;MCI组中,197人有活动性发作,226人有远程发作。
  • 正常认知成人中,活动性发作与认知损害风险升高2.1倍相关(aHR 2.13,95%CI 1.60-2.84,p<0.001);中位下降年数:活动性发作约1年,远程发作约3年,无发作约3年。
  • MCI者中,活动性发作与痴呆风险升高1.6倍相关(aHR 1.58,95%CI 1.24-2.01,p<0.001);中位下降年数:活动性发作约1年,远程发作约2年,对照约2年。
  • 远程发作未观察到上述风险。

临床怎么用

  • 作者认为早期识别和管理癫痫发作可能为减轻老龄化癫痫人群的认知下降提供途径。

局限性

  • 原文指出局限性为:在观察性纵向研究中无法确认因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Seizures are common in dementia and associated with accelerated cognitive decline. However, the impact of active vs remote seizures on cognition remains understudied. This study aimed to investigate the impact of active vs remote seizures on cognition in people with normal cognition and mild cognitive impairment (MCI). METHODS: This longitudinal, multicenter cohort is based on National Alzheimer's Coordinating Center data of participants recruited from 39 Alzheimer's Disease Centers in the United States from September 2005 to December 2021. All participants with normal cognition and MCI and at least 2 visits were included. Primary outcome, that is, cognitive decline, was determined using Clinical Dementia Rating (CDR) from (1) normal-to-impaired (CDR ≥0.5) and (2) MCI-to-dementia (CDR ≥1) groups. The effect of active seizures (over the preceding 12 months), remote seizures (previous seizures but none over the preceding 12 months), and no seizures (controls) on cognition was assessed. Subgroups of chronic seizures at enrollment and new-onset seizures were further analyzed. Cox regression models assessed the risk of all-cause MCI and/or dementia. All models were adjusted for age, sex, education, race, hypertension, and diabetes. RESULTS: Of the 13,726 participants with normal cognition at enrollment (9,002 [66%] female; median age 71 years), 118 had active seizures and 226 had remote seizures. Of the 11,372 participants with MCI at enrollment (5,605 [49%] female; median age 73 years), 197 had active seizures and 226 had remote seizures. Active seizures were associated with 2.1 times higher risk of cognitive impairment (adjusted hazard ratio [aHR] 2.13, 95% CI 1.60-2.84, p < 0.001) in cognitively healthy adults (median years to decline: active seizures = ∼1, remote seizures = ∼3, no seizures = ∼3) and 1.6 times higher risk of dementia (aHR 1.58, 95% CI 1.24-2.01, p < 0.001) in those with MCI (median years to decline: active seizures = ∼1, remote seizures = ∼2, controls = ∼2). This risk was not observed with remote seizures. DISCUSSION: In this study, active seizures but not remote seizures were associated with earlier cognitive decline in both cognitively normal adults and those with MCI, independent of other dementia risk factors. Therefore, early identification and management of seizures may present a path to mitigation of cognitive decline in the aging epileptic population. A limitation is that causality cannot be confirmed in our observational longitudinal study.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Zawar I, Kapur J, Mattos MK, et al. Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment. Neurology. 2024. PMID: 39173101. doi:10.1212/WNL.0000000000209820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。